Emtricitabine - PDFSEARCH.IO - Document Search Engine

Emtricitabine
Results: 375

#	Item
21	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas Add to Reading List Source URL: cdn.salix.com Language: English - Date: 2014-07-10 09:25:59 Carbamates Organofluorides Gilead Sciences Organochlorides Alkynes Darunavir Antiretroviral drug Tenofovir/emtricitabine Lamivudine Chemistry Organic chemistry Pharmacology
22	Microsoft Word - Backgrounder - final Add to Reading List Source URL: www.adarc.org Language: English - Date: 2013-07-10 16:35:53 Gilead Sciences Microbiology Sexually transmitted diseases and infections Microbicides Pre-exposure prophylaxis Epidemiology Tenofovir/emtricitabine HIV Tenofovir Medicine Health HIV/AIDS
23	Lessons from Oral PrEP Trials: iPrEx Dave Glidden Division of Biostatistics University of California at San Francisco Add to Reading List Source URL: www.adarc.org Language: English - Date: 2013-07-10 16:52:06 Fixed dose combination Pre-exposure prophylaxis Tenofovir/emtricitabine Clinical research Health Gilead Sciences IPrEx Medicine
24	Microsoft Word - cfh1203 rilpivirine-emtricitabine-tenofovir eviplera BRF.DOC Add to Reading List Source URL: www.zorginstituutnederland.nl - Date: 2013-03-12 06:36:16
25	GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations Add to Reading List Source URL: gilead.com Language: English - Date: 2013-02-24 19:40:20 Organofluorides Pharmacology Integrase inhibitors Tenofovir Emtricitabine Gilead Cobicistat Elvitegravir GS Gilead Sciences Chemistry Organic chemistry
26	This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a Add to Reading List Source URL: gilead.com Language: English - Date: 2013-02-25 18:48:52 Pharmacology Organic chemistry Fixed dose combination Organofluorides Emtricitabine/tenofovir/efavirenz Tenofovir Emtricitabine Gilead Efavirenz Gilead Sciences Bristol-Myers Squibb Chemistry
27	HIGHLIGHTS OF PRESCRIBING INFORMATION  New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine Add to Reading List Source URL: www.gilead.com Language: English - Date: 2013-10-28 13:55:09 Bristol-Myers Squibb Organofluorides Pharmacology Fixed dose combination Carbamates Tenofovir Lamivudine Reverse-transcriptase inhibitor Emtricitabine/tenofovir/efavirenz Gilead Sciences Chemistry Organic chemistry
28	STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY Add to Reading List Source URL: health.tn.gov Language: English - Date: 2015-03-19 15:53:21 Fixed dose combination Gilead Sciences Organofluorides Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Reverse-transcriptase inhibitor ATC code J05 Emtricitabine Fixed-dose combination Chemistry Organic chemistry Pharmacology
29	PATIENT INFORMATION VIREAD® (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be new information. Add to Reading List Source URL: www.gilead.com Language: English - Date: 2015-05-29 13:25:40 Sexually transmitted diseases and infections Microbiology HIV/AIDS Fixed dose combination Purines Tenofovir Emtricitabine Hepatitis B Darunavir Gilead Sciences Medicine Health
30	Microsoft Word - FPC QHP Policy Guide Febdoc Add to Reading List Source URL: fairpricingcoalition.org Language: English - Date: 2014-02-05 17:34:29 Gilead Sciences HIV/AIDS Pharmaceuticals policy Bristol-Myers Squibb Emtricitabine/tenofovir/efavirenz AIDS Medicare Part D Tenofovir Formulary Health Medicine Pharmacology

UPDATE